Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04325529 · ClinicalTrials.gov registry record
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
A clinical trial of Major Depression in Remission, sponsored by Mclean Hospital.
- Active
- Registry status
- 148
- Enrollment target
- 1
- Study location
NCT04325529: Active study of Major Depression in Remission, sponsored by Mclean Hospital.
NCT04325529 is a study of Major Depression in Remission that is active but no longer recruiting, run by Mclean Hospital. The registered enrollment target is 148 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04325529, a study of Major Depression in Remission, is active but no longer recruiting, sponsored by Mclean Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates how remitted individuals with past major depressive disorder (MDD) make approach-avoidance decisions and which brain regions are implicated in such decisions. Information collected through MRI and behavioral tasks will be used to predict depressive symptoms in the future.
Primary Outcome
For assessing psychological state
Conditions Studied
Interventions
- DEVICE Aversive stimuli
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT04325529 still lists
NCT04325529 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Major Depression in Remission appearing as the primary indexed condition, and to 1 intervention - of which Aversive stimuli is the first listed.
NCT04325529 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04325529 about?
NCT04325529 is a clinical study titled "Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)". This study investigates how remitted individuals with past major depressive disorder (MDD) make approach-avoidance decisions and which brain regions are implicated in such decisions. Information collected through MRI and behavioral tasks will be used to predict depressive symptoms in the future.
What is the current status of trial NCT04325529?
This trial is currently active not recruiting. The enrollment target is 148 participants. The study started on 2021-01-19. Estimated completion is 2026-06-30.
What conditions does trial NCT04325529 study?
This clinical trial studies the following conditions: Major Depression in Remission.
What interventions are being tested in trial NCT04325529?
The interventions under investigation include: Aversive stimuli (DEVICE).
Who is sponsoring clinical trial NCT04325529?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04325529 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI